Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: A Study of Neoadjuvant SHR6390 in Combination With Anastrozole, Pyrotinib, and Trastuzumab in Patients With ER+/HER2+ Breast Cancer. [Phase 2]
Phase 2 study evaluating neoadjuvant SHR6390 with anastrozole, pyrotinib, and trastuzumab in ER+/HER2+ breast cancer is in progress with unk…
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer [Phase 1, Phase 2]
Phase 1/2 trial update for an experimental in-situ cancer vaccine across multiple solid tumors, including breast, colorectal, prostate, mela…
-
FDA approval · 2020-01-21FDA Approved: KISQALI — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for KISQALI (ribociclib) submitted by Novartis Pharmaceuticals Corporation. The action updates the p…
-
FDA approval · 2020-01-21FDA Approved: KISQALI FEMARA CO-PACK — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application to co-pack Kisqali (ribociclib) with Femara (letrozole) in a single package, enabling a combined…
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients [Phase 3]
Phase 3 trial comparing TAC chemotherapy with or without zoledronic acid in HER2-negative breast cancer; study completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study [Phase 2]
A Phase 2 pilot study evaluating nicotinic treatment for post-chemotherapy subjective cognitive impairment (often called chemo brain) has co…
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Quell Opioid Reduction and Pain Relief in Patients With Cancer [NA]
A terminated clinical trial update for Quell opioid reduction and pain relief in cancer patients, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Evaluating New Surgical Technique in Management of Female Patients With Operable Multifocal Breast Cancer [NA]
A clinical trial update evaluating a new surgical technique for operable multifocal breast cancer in female patients. Status and results are…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer [Phase 3]
Phase 3 trial comparing 8 continuous vs 8 intermittent cycles in first/second line treatment for HER2-negative metastatic breast cancer has …
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast Cancer
A completed clinical trial evaluating predictive and prognostic tools to optimize frontline therapy with bevacizumab in HER2-negative aggres…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer [Phase 2]
Phase II study assessing neoadjuvant weekly paclitaxel and carboplatin followed by dose-dense epirubicin and cyclophosphamide in stage II-II…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Ketorolac in Breast Cancer Surgery [Phase 3]
Phase 3 clinical trial investigating ketorolac in breast cancer surgery has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer [Phase 2]
Phase 2 trial comparing oral CDB-4124 to placebo in stage I-II primary breast cancer is ongoing with unknown status.
-
FDA approval · 2020-01-16FDA Approved: PERJETA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Perjeta (pertuzumab) by Genentech, resulting in changes to the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography [Phase 2]
Phase 2 clinical trial updating functional status of estrogen receptors in breast cancer using positron emission tomography; study completed…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Quantitative Subharmonic Breast Imaging [Phase 4]
Phase 4 clinical trial update for Quantitative Subharmonic Breast Imaging in breast cancer; results posted January 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy [Phase 2]
A Phase 2 trial evaluating propranolol in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy has completed wit…
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients [Phase 4]
Phase 4 trial comparing tapering low-dose dexamethasone to standard-of-care therapies for treatment-associated pain syndrome in early-stage …
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer [Phase 2]
A Phase 2 pilot study evaluating denosumab’s impact on disseminated tumor cells in patients with early-stage breast cancer; study terminated…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab [Phase 3]
A Phase 3 trial comparing paclitaxel plus bevacizumab to capecitabine plus bevacizumab in metastatic breast cancer has completed with result…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Mithramycin for Lung, Esophagus, and Other Chest Cancers [Phase 2]
Phase 2 trial of Mithramycin for lung, esophageal, and other chest cancers was terminated; results posted in 2019.
-
FDA approval · 2019-12-27FDA Approved: LYNPARZA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for LYNPARZA (olaparib) from AstraZeneca Pharmaceuticals LP. The approval updates the product labeli…
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy [NA]
This clinical trial update describes a completed study evaluating caloric restriction as an adjunct to surgery and radiation in patients wit…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain [Phase 2]
Phase 2 trial update of abemaciclib in participants with brain-metastatic breast cancer, non-small cell lung cancer, or melanoma; study comp…
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating paclitaxel in combination with trastuzumab and lapatinib in HER2-positive early-stage breast cancer has …